MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Tics Exacerbations in Adults with Tic Disorders: A Case series

S. Schaefer, C. Chow, E. Louis, D. Robakis (New Haven, CT, USA)

Meeting: 2017 International Congress

Abstract Number: 1159

Keywords: Tics(also see Gilles de la Tourette syndrome): Clinical features, Tics(also see Gilles de la Tourette syndrome): Treatment

Session Information

Date: Wednesday, June 7, 2017

Session Title: Tics/Stereotypies

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To identify patterns of tic re-emergence in adult patients with a history of childhood tics.

Background: Tics and Tourette syndrome (TS) have been described as peaking in childhood and early adolescence with regression as patients enter adulthood. In this series, we report patients who belong to a little-described subset of TS patients: those who were diagnosed with TS during childhood who then experienced a period of relief from or absence of symptoms followed by tic re-emergence in adulthood.

Methods: We performed a retrospective chart review of outpatients over age 21 seen at the Yale Medical Group neurology clinic between January 2012 and July 2016 who were diagnosed by a movement disorders neurologist with childhood onset tics or TS, and who experienced a latent period of relative tic abatement (defined as a significant reduction in or absence of tics) followed by exacerbation.

Results: Sixteen patients were identified. The mean latent period of tic abatement was 16 years, range 3-35 years. Ten patients (62.5%) identified a trigger for their exacerbation; common triggers were work-related, interpersonal, or involved changes in substance use. Three patients (18.8%) reported that the phenomenology of their tics during the exacerbation had evolved since childhood, and seven patients (43.8%) reported that their tics were now worse. Six patients (37.5%) had received medications for tics as children, and 15 patients (93.8%) received pharmacological intervention for their tics during the adulthood exacerbation. Six of fifteen patients (40.0%) had a documented effective response from those pharmacological intervention(s).

Conclusions: 1) Our study, which represents the largest single series to date of adults with tic recurrences, raises the possibility that the steady decline in symptoms many patients experience as they enter their early 20s may in fact represent temporary improvement.  2) The period of tic abatement lasted years in our patients, different from the more rapid fluctuations in children. 3) As in children, psychosocial and vocational stressors were common triggers in this study, but substance-related issues may also be an important trigger in adults. 3) Patient desire for pharmacological intervention was not necessarily correlated with worsening tic severity. Treatment is challenging, and multiple medications may need to be trialed for optimal efficacy.

To cite this abstract in AMA style:

S. Schaefer, C. Chow, E. Louis, D. Robakis. Tics Exacerbations in Adults with Tic Disorders: A Case series [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/tics-exacerbations-in-adults-with-tic-disorders-a-case-series/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/tics-exacerbations-in-adults-with-tic-disorders-a-case-series/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley